TECH
Companies
NASDAQ
Bio-Techne Corporation
Health Care
$50.13
-$21.70 (-30.21%)
Price Chart
Overview
About TECH
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.
Market Cap
$12.2B
Volume
143.3M
Avg. Volume
124.1M
P/E Ratio
22.442923
Dividend Yield
0.00%
Employees
2.3K
Company Information
Latest News for TECH
Risk & Correlation Analysis
Market Correlation
0.71
Low Correlation
Volatility
Medium (0.36)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TECH shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$12.2B
Volume143.3M
P/E Ratio22.44
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025